Ovarian cancer is often called a “silent killer” for a reason—most cases aren’t found until it’s too late. But that’s starting to change.
In this deep dive, we walk through what really makes this cancer so hard to catch early, and what’s finally starting to shift thanks to new testing, smarter treatments, and deeper knowledge about our genes.
You’ll hear about:
- Why most ovarian cancers are still diagnosed in stage 3 or 4
- The major types of ovarian cancer—and why it’s not “just one disease”
- How BRCA1, BRCA2, and other gene mutations shape risk and treatment
- The promise of blood-based screening and personalized therapies
- What to know about surgery, chemo, recurrence, and side effects
- Where clinical trials fit in—and why they matter more than ever
If you or someone you love has faced this diagnosis—or you’re just trying to stay informed—this episode breaks down the key facts and latest progress without the jargon.
